Phagenesis, Series

Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management

Published on 08/07/2025 at 18:03 | prnewswire.co.uk

Phagenesis United Kingdom United States of America Germany Spain Arizona

View original content:https://www.prnewswire.co.uk/news-releases/phagenesis-a-medical-device-company-specializing-in-the-treatment-of-swallowing-disorders-successfully-closes-a-42m-series-d-financing-round-led-by-eqt-life-sciences-and-sectoral-asset-management-302077510.html

en | boerse | 67999688 |